HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Osteoporosis in patients of different age groups: clinical and pathogenetic aspects and treatment with the use of Osteomed, Osteo-Vit D3 and Osteomed Forte drugs

DOI: https://doi.org/10.29296/25877305-2021-09-13
Issue: 
9
Year: 
2021

Professor D. Dedov, MD Tver State Medical University Tver Regional Clinical Cardiology
Dispensary

The article discusses the clinical and pathogenetic aspects and tactics of management of patients with osteoporosis of various age groups. It is concluded that an individual approach should be used in the treatment of these patients with a preliminary determination of the etiology, pathogenesis, clinical symptoms of osteoporosis and subsequent differentiated administration of the drugs Osteomed, Osteo-Vit D3 or Osteomed Forte, taking into account the age and gender of a particular patient.

Keywords: 
treatment
osteoporosis
age
patients
clinic
pathogenesis
Osteomed
Osteo-Vit D3
Osteomed Forte



References: 
  1. Mel'nichenko G.A., Belaja Zh.E., Rozhinskaja L.Ja. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike, lecheniju i profilaktike osteoporoza. Problemy endokrinologii. 2017; 63 (6): 392–426 [Mel’nichenko G.A., Belaya Zh.E., Rozhinskaya L.Ya. et al. Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis. Problems of Endocrinology. 2017; 63 (6): 392–426 (in Russ.)]. DOI: 10.14341/probl2017636392-426
  2. Skripnikova I.A., Gur'ev A.V., Shal'nova S.A. i dr. Rasprostranennost' klinicheskih faktorov, ispol'zuemyh dlja otsenki riska osteoporoticheskih perelomov. Profilakticheskaja meditsina. 2016; 19 (5): 32–40 [Skripnikova I.A., Gur’ev A.V., Shalnova S.A. et al. The prevalence of clinical factors used for risk assessment of osteoporotic fractures. Profilakticheskaya Meditsina. 2016; 19 (5): 32–40 (in Russ.)]. DOI: 10.17116/profmed201619532-40
  3. Mjagkova M.A., Skripnikova I.A., Shal'nova S.A. i dr. Assotsiatsii 10-letnej verojatnosti osteoporoznyh perelomov s summarnym serdechno-sosudistym riskom i serdechno-sosudistymi zabolevanijami, obuslovlennymi aterosklerozom, sredi gorodskogo i sel'skogo naselenija. Profilakticheskaja meditsina. 2021; 24 (6): 18–27 [Myagkova M.A., Skripnikova I.A., Shalnova S.A. et al. Associations of the 10-year probability of osteoporotic fractures with the total cardiovascular risk and cardiovascular diseases due to atherosclerosis among urban and rural populations. Profilakticheskaya Meditsina. 2021; 24 (6): 18–27 (in Russ.)]. DOI: 10.17116/profmed20212406118
  4. Mjagkova M.A., Skripnikova I.A., Shal'nova S.A. i dr. Analiz rasprostranennosti klinicheskih faktorov riska osteoporoznyh perelomov sredi gorodskogo i sel'skogo naselenija RF (po dannym epidemiologicheskogo issledovanija ESSE-RF-2). Profilakticheskaja meditsina. 2020; 23 (6): 60–8 [Myagkova M.A., Skripnikova I.A., Shalnova S.A. et al. Analysis of the prevalence of clinical risk factors of osteoporotic fractures among urban and rural populations of the Russian Federation (according to the epidemiological study ESSE-RF-2). Profilakticheskaya Meditsina. 2020; 23 (6): 60–8 (in Russ.)]. DOI: 10.17116/profmed20202306160
  5. Prohorov M., Kislov A., Elistratov D. i dr. Vlijanie osteomeda na konsolidatsiju perelomov kostej. Vrach. 2016; 2: 68–9 [Prokhorov M., Kislov A., Elistratov D. et al. Effect of Osteomed on consolidation of bone fractures. Vrach. 2016; 2: 68–9 (in Russ.)].
  6. Strukov V., Elistratov D., Balykova L. i dr. Perelomy kostej u detej i podrostkov – integral'nyj pokazatel' osteoporoza. Vrach. 2015; 1: 17–20 [Strukov V., Elistratov D.G., Balykova L. et al. Fractures of bones at children and teenagers – the integrated indicator of osteoporosis. profilakti’s optimization and treatments. Vrach. 2015; 1: 17–20 (in Russ.)].
  7. Kuptsova T., Kislov A., Strukov V. i dr. Osteo-Vit D3 v lechenii detej s povtornymi perelomami kostej pri osteoporoze. Vrach. 2016; 1: 46–7 [Kuptsova T., Kislov A., Strukov V. et al. Osteo-Vit D3 in the treatment of children with recurrent bone fractures in osteoporosis. Vrach. 2016; 1: 46–7 (in Russ.)].
  8. Strukov V., Kislov A., Elistratov D. i dr. Personifitsirovannyj podhod v terapii osteoporoza u pozhilyh. Vrach. 2015; 6: 51–3 [Strukov V., Kislov A., Elistratov D. et al. Personified approach in the therapy of osteoporosis in elderly patients. Vrach. 2015; 6: 51–3 (in Russ.)].